No photo of Paul F. Riska

View Scopus Profile

Paul F. Riska, M.D.

  • 1040 Citations
  • 17 h-Index
1989 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paul F. Riska is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

MYCOBACTERIOPHANGE INTERACTION WITH M TUBERCULOSIS

Riska, P. F.

National Institute of Allergy and Infectious Diseases

7/15/98 → 6/30/99

Project: Research project

    • Publications

    • 1040 Citations
    • 17 h-Index
    • 29 Article
    • 1 Review article

    Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

    INSIGHT FLU-IVIG Study Group, Nov 2019, In : The Lancet Respiratory Medicine. 7, 11, p. 951-963 13 p.

    Research output: Contribution to journal › Article

    Open Access
    • 15 Scopus citations

    Effect of algorithm-based therapy vs usual care on clinical success and serious adverse events in patients with staphylococcal bacteremia a randomized clinical trial

    the Staphylococcal Bacteremia Investigators, Sep 25 2018, In : JAMA - Journal of the American Medical Association. 320, 12, p. 1249-1258 10 p.

    Research output: Contribution to journal › Article

    • 19 Scopus citations

    Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    For the INSIGHT FLU003 Plus Study Group, Jan 1 2018, In : Open Forum Infectious Diseases. 5, 1, ofx228.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Two for the price of one: Emerging carbapenemases in a returning traveller to New York City

    Mittal, J., Szymczak, W. A., Guo, Y., Levi, M. H., Chen, L., Kreiswirth, B. N., Riska, P. F. & Nori, P., Jan 1 2018, In : BMJ case reports. 2018, bcr-2018-225440.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

    CoDIFy study group & CoDIFy study group, Jul 2017, In : The Lancet Infectious Diseases. 17, 7, p. 735-744 10 p.

    Research output: Contribution to journal › Article

    • 45 Scopus citations